MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ENZN has $42,813K in assets. $42,574K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
5856.77%
Quick Ratio
5856.77%
Cash Ratio
5824.08%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Other current assets
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Series c preferred stock - 0.01 ...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
42,574
Other current assets
239
Total current assets
42,813
Total assets
42,813
Accounts payable
331
Accrued expenses and other current liabilities
400
Total current liabilities
731
Series c preferred stock - 0.01 par value, 40,000 shares authorized, issued and outstanding (liquidation value 1,115 per share and 1,062 per share) at december 31, 2025 and 2024, respectively-Series CPreferred Stock
44,607
Common stock - 0.01 par value, authorized 170,000,000 shares issued and outstanding 74,214,603 shares at december 31, 2025 and 2024
742
Additional paid-in capital
70,034
Accumulated deficit
-73,301
Total stockholders' (deficit) equity
-2,525
Total liabilities, mezzanine equity and stockholders' (deficit) equity
42,813
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$42,574K Other current assets$239K Total current assets$42,813K Total assets$42,813K Accumulated deficit-$73,301K Total liabilities,mezzanine equity and...$42,813K Total stockholders'(deficit) equity-$2,525K Additional paid-in capital$70,034K Common stock - 0.01 parvalue, authorized...$742K Series c preferredstock - 0.01 par value,...$44,607K Total currentliabilities$731K Accrued expenses andother current...$400K Accounts payable$331K

ENZON PHARMACEUTICALS, INC. (ENZN)

ENZON PHARMACEUTICALS, INC. (ENZN)